Skip to main content
Fig. 3 | Microbiome

Fig. 3

From: Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo

Fig. 3

Synergistic intake of probiotics didn’t affect the therapeutic effect of lovastatin on hyperlipidemia, but was conducive to liver protection in vivo. A–G Serum T-CHO, TG, LDL-C, HDL-C, insulin, TBA, and TNF-α concentrations measured by ELISA (Wilcoxon rank-sum test, *p < 0.05, **p < 0.01). H Representative histological sections stained by H&E of liver tissue at 20 × magnification

Back to article page

Microbiome

ISSN: 2049-2618

Contact us